Top headlines: Record dividend for Tata Sons, govt testing for cough syrup

Business Standard brings you top news at this hour

BS Web Team New Delhi
Tata Sons set to earn record dividend worth nearly Rs 33,350 cr in FY23

Listen to This Article

US seeks enterprise-based probe into errant firms under IPEF deal
The US has put forward a proposal under which member countries of the Indo-Pacific Economic Framework (IPEF) can seek enterprise-based investigation to address specific concerns in a company through a Tripartite Labour Committee comprising a representative each from the government, employer, and labour union. Read more...

Tata Sons set to earn record dividend worth nearly Rs 33,350 cr in FY23
Thanks to a big payout by the group’s cash cow, Tata Consultancy Services (TCS), Tata Sons is set to earn a record-high equity dividend worth nearly Rs 33,350 crore from the group’s listed companies for FY23, up 130 per cent from Rs 14,529 crore in FY22.

Nearly 90 per cent of this, or around Rs 30,500 crore, is estimated to accrue to Tata Sons while the rest will show up in its profit & loss account for FY24. Read more...
Under the lens: Regulator moots pre-export govt testing for cough syrup cos

Also Read

WHO stands by action of issuing alert against Maiden Pharma cough syrup

Maiden Pharma's cough syrups are safe, WHO jumped the gun: DCGI

Swiggy shuts premium grocery delivery service 'Handpicked' in Bengaluru

US investment firm Invesco slashes Swiggy valuation by 33% to $5.5 billion

After Gambia, now Uzbekistan alleges Indian cold drug killed its children

Look at EU regulations: Jaishankar tells Borrell on import of Russian oil

Uttar Pradesh govt hikes DA by 4% for state employees and pensioners

Citizens in Mumbai to receive weather updates on phones during monsoon: BMC

First Trade-Tech meet significant milestone in India-EU ties: Jaishankar

164 'positive indigenisation list' items indigenised: Defence ministry

After reports of contamination in cough syrups sent from the country, India is considering a system to test them before exporting.
It is learnt that the Central Drugs Standard Control Organisation (CDSCO) has sent a proposal to the Union health ministry on this. The idea is to test the medicines at government labs before exporting. Read more...

US investor Baron Capital slashes Swiggy's valuation by 34% to $7.1 bn
Food delivery giant Swiggy is witnessing another markdown in its valuation by an investor. A fund managed by US-based asset management firm Baron Capital Group has slashed the valuation of Swiggy by 34 per cent to $7.1 billion as of December 2022, according to filings with USA's Securities and Exchange Commission (SEC). The filing for this period was submitted in March this year. Read more...

Natural disasters: 2.5 million displaced in India in 2022, shows data
A range of natural disasters displace millions of Indians each year. An analysis of data from the Geneva-based Internal Displacement Monitoring Centre (IDMC) shows that Internal displacement in India was 2.5 million in 2022. The average displacement in the country in the last seven years has been over 3 million annually. Read more...

First Published: May 17 2023 | 7:28 AM IST

Explore News